MedEdge Holdings Formed Through $450 Million Management-Led Buyout of Abyrx and Kairuku

Bain Capital to Acquire HealthEdge from Blackstone Funds

April 8, 2025

Cloud & SaaS

Bain Capital's Private Equity team has agreed to acquire HealthEdge, a Burlington, Massachusetts–based healthcare SaaS platform, from funds managed by Blackstone. Financial terms were not disclosed; the transaction is expected to close in Q2 2025 and positions Bain to accelerate HealthEdge's product growth and GenAI enablement for health plans.

Maverix Medical Acquires Cirrus Bio

March 29, 2024

Biotechnology

Maverix Medical, a lung cancer platform backed by Ajax Health, KKR, and Hologic, has acquired Cirrus Bio to form the foundation of a new diagnostics division, Maverix Dx. Cirrus Bio's multiomic diagnostic capabilities and its founders, David Mallery (CEO) and Scott Morris (CSO), will lead Maverix Dx as the platform pursues further diagnostic product development and M&A.

KKR to Acquire Healthium MedTech from Apax Funds

May 6, 2024

Medical Devices

KKR (through funds it manages) has signed definitive agreements to acquire a controlling interest in Healthium MedTech Ltd. from funds advised by Apax Partners. The transaction, expected to close in Q3 2024 subject to regulatory approvals, will support Healthium's next phase of global growth and product/market expansion.

Banyan Software Acquires Medtech Global

February 19, 2025

Software

Banyan Software has acquired 100% of Medtech Global, a New Zealand–headquartered provider of practice management and health technology solutions including Medtech Evolution, Artia, Medeor and ALEX. The seller parties were Advent Partners and Geoffrey Sayer (Medtech CEO), who will remain as CEO under Banyan's ownership; the deal strengthens Banyan's healthcare software footprint across Australia and New Zealand.

KKR Acquires Bushu Pharmaceuticals from BPEA EQT

December 20, 2022

Pharmaceuticals

KKR has agreed to acquire Bushu Pharmaceuticals, a leading Japanese pharmaceutical CDMO headquartered in Kawagoe, from the BPEA V Fund (BPEA EQT). Bushu operates four manufacturing facilities across Japan, employs around 1,600 people, and provides contract development and manufacturing services for pharmaceuticals and medical devices; the deal is expected to close in Q1 2023 subject to customary approvals.

Kindeva Drug Delivery (Altaris) Acquires Summit Biosciences

January 18, 2024

Medical Devices

Kindeva Drug Delivery, an operating company of healthcare investor Altaris, has acquired Summit Biosciences from its founding family shareholders. The acquisition adds Summit’s FDA- and EMA-approved 55,000 sq. ft. cGMP intranasal CDMO facility in Lexington, Kentucky, expanding Kindeva’s nasal drug‑delivery platform and global manufacturing footprint.